Medicine and Dentistry
Prostate Cancer
100%
Biopsy Technique
75%
Neoadjuvant Chemotherapy
66%
Cohort Analysis
48%
Chemotherapy
44%
Malignant Neoplasm
44%
Tumor Regression
39%
Esophageal Adenocarcinoma
38%
Stomach Adenocarcinoma
33%
Medical Research
33%
Bladder Cancer
33%
Lymph Node
33%
Recurrent Disease
33%
Pancreas Cancer
33%
Immunoglobulin G
33%
Esophageal Cancer
33%
Apolipoprotein
33%
Hazard Ratio
30%
Neoplasm
26%
Disease Exacerbation
25%
Prostate Specific Antigen
25%
Exercise Intervention
22%
Odds Ratio
22%
Prostate Biopsy
16%
Lenabasum
16%
Diseases
16%
Ethnic Groups
16%
Adverse Event
14%
Postoperative Complication
14%
Logistic Regression Analysis
13%
Chronic Disease
13%
Functional Assessment
13%
Informed Consent
13%
Immunoglobulin M
13%
Immunoglobulin A
13%
Vasculotropin
11%
Spontaneous Remission
11%
CD8 Antigen
11%
CD3 Antigen
11%
Interleukin 6
11%
Humoral Immunity
10%
Proportional Hazards Model
9%
Fluorouracil
9%
Outcome Assessment
8%
Health System
7%
Cancer Research
6%
Health Status
6%
Diet Quality
6%
English (Language)
6%
Physical Activity
6%
Immunology and Microbiology
Immunoglobulin A
52%
Immunoglobulin M
52%
Blood Level
38%
Immunoglobulin Class
33%
Immunoglobulin Blood Level
33%
Immunoglobulin G
33%
Immunoglobulin E
33%
Apolipoprotein
33%
Autoantibodies
33%
Humoral Immunity
30%
Antibody Blood Level
16%
Helicobacter Pylori
16%
P53
16%
Tumor Antigen
16%
Infectious Agent
16%
Wart Virus
16%
Hepatitis B Virus
16%
MUC1
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Cancer
66%
Apolipoprotein
66%
Cohort Study
36%
Chemotherapy
33%
Immunoglobulin G
33%
Haptoglobin
33%
Chronic Inflammation
33%
Stomach Adenocarcinoma
33%
Albumin
14%
Immunoglobulin M
13%
Immunoglobulin A
13%
Adverse Event
8%
Postoperative Complication
8%
Chronic Pancreatitis
8%
Fluorouracil
5%
